Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT03263533
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with DSM-5 Schizophrenia
* Receiving stable dose pf clozapine (≥ 300 mg per day) for at least 6 months before entering the study
Exclusion Criteria:
* Taking specific psychotropic medications (lamotrigine and valproic acid)
* Current or recent (12-months) substance use or induced disorder
* History of significant neurological or medical disorders
* Intellectual disability
* Known contraindications to the administration of vorinostat per product labeling
* Women currently pregnant, planning to become pregnant, or receiving hormone therapy and refusing any form of birth control
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT03263533
Study Brief:
Protocol Section:
NCT03263533